188 related articles for article (PubMed ID: 28932850)
1. Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents.
Oliveri V; Lanza V; Milardi D; Viale M; Maric I; Sgarlata C; Vecchio G
Metallomics; 2017 Oct; 9(10):1439-1446. PubMed ID: 28932850
[TBL] [Abstract][Full Text] [Related]
2. Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.
Zuo J; Bi C; Fan Y; Buac D; Nardon C; Daniel KG; Dou QP
J Inorg Biochem; 2013 Jan; 118():83-93. PubMed ID: 23142973
[TBL] [Abstract][Full Text] [Related]
3. Coordination of hydroxyquinolines to a ruthenium bis-dimethyl-phenanthroline scaffold radically improves potency for potential as antineoplastic agents.
Heidary DK; Howerton BS; Glazer EC
J Med Chem; 2014 Nov; 57(21):8936-46. PubMed ID: 25314373
[TBL] [Abstract][Full Text] [Related]
4. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
[TBL] [Abstract][Full Text] [Related]
5. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.
Daniel KG; Chen D; Orlu S; Cui QC; Miller FR; Dou QP
Breast Cancer Res; 2005; 7(6):R897-908. PubMed ID: 16280039
[TBL] [Abstract][Full Text] [Related]
6. L-Ornithine Schiff base-copper and -cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells.
Zhang Z; Bi C; Fan Y; Zhang N; Deshmukh R; Yan X; Lv X; Zhang P; Zhang X; Dou QP
J Biol Inorg Chem; 2015 Jan; 20(1):109-121. PubMed ID: 25467055
[TBL] [Abstract][Full Text] [Related]
7. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
8. Novel proteasome inhibitors to overcome bortezomib resistance.
Ruschak AM; Slassi M; Kay LE; Schimmer AD
J Natl Cancer Inst; 2011 Jul; 103(13):1007-17. PubMed ID: 21606441
[TBL] [Abstract][Full Text] [Related]
9. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
[TBL] [Abstract][Full Text] [Related]
10. Anti-Prostate Cancer Activity of 8-Hydroxyquinoline-2-Carboxaldehyde-Thiosemicarbazide Copper Complexes by Fluorescent Microscopic Imaging.
Xie F; Peng F
J Fluoresc; 2017 Nov; 27(6):1937-1941. PubMed ID: 28653241
[TBL] [Abstract][Full Text] [Related]
11. Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells.
Skrott Z; Cvek B
Mini Rev Med Chem; 2012 Oct; 12(12):1184-92. PubMed ID: 22931589
[TBL] [Abstract][Full Text] [Related]
12. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
13. Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.
Milacic V; Jiao P; Zhang B; Yan B; Dou QP
Int J Oncol; 2009 Dec; 35(6):1481-91. PubMed ID: 19885572
[TBL] [Abstract][Full Text] [Related]
14. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.
Daniel KG; Gupta P; Harbach RH; Guida WC; Dou QP
Biochem Pharmacol; 2004 Mar; 67(6):1139-51. PubMed ID: 15006550
[TBL] [Abstract][Full Text] [Related]
15. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
[TBL] [Abstract][Full Text] [Related]
16. New 8-hydroxyquinoline galactosides. The role of the sugar in the antiproliferative activity of copper(II) ionophores.
Oliveri V; Viale M; Aiello C; Vecchio G
J Inorg Biochem; 2015 Jan; 142():101-8. PubMed ID: 25450024
[TBL] [Abstract][Full Text] [Related]
17. Cupriphilic compounds to aid in proteasome inhibition.
Mukherjee S; Sparks R; Metcalf R; Brooks W; Daniel K; Guida WC
Bioorg Med Chem Lett; 2016 Aug; 26(15):3826-9. PubMed ID: 27311892
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
[TBL] [Abstract][Full Text] [Related]
19. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.
Han J; Liu L; Yue X; Chang J; Shi W; Hua Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):477-83. PubMed ID: 24060341
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
